(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. A dfer gain-of-function mutant affects dorsal closure, the
morphology of leading edge and amnioserosal cells. (A,B)
Late stage 16 wild-type embryo (A), stained for the cell adhesion molecule
Fasciclin 3, is dorsally closed, whereas an equivalently staged
dfergof embryo (B) is still open. (C) At stage 14,
wild-type leading edge cells develop an actomyosin cable (up arrowhead; white,
Alexa568-Phalloidin), and numerous filopodia (down arrowhead). F-actin is
enriched at amnioserosal cell borders (double arrowhead; same embryo as is
shown in Fig. 4D). (D)
In dfergof mutants, the actomyosin cable is thinner (up
arrowhead), and the filopodia less abundant (down arrowheads). Amnioserosal
cells show weaker F-actin staining at cell-cell junctions (double arrowhead).
Contraction of individual amnioserosal cells still occurs (up arrow).
(E) In wild-type embryos, GFP-Actin highlights the actomyosin cable (up
arrowhead), filopodia (down arrowhead) and cortical enrichment in amnioserosal
cells (double arrowhead; UAS-GFP-Actin/+; daGAL4/+; stage 14). (F) In
dfergof embryos, the actomyosin cable and filopodia are
reduced, and amnioserosal cells show less cortical actin and a more motile
morphology (arrowhead;
UAS-GFP-Actin/+;daGAL4,dfergof/dfergof;
stage 14).